BBA
MREO

Baker Bros. Advisors’s Mereo BioPharma MREO Stock Holding History

Baker Bros. Advisors’s Portfolio MREO Stock Details MREO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		– Sell
-3,554,979
Closed -$4.69M – 106
2023
Q2 		$4.69M Buy
+3,554,979
New +$4.12M 0.03% 74
2021
Q4 		– Sell
-292,692
Closed -$708K – 124
2021
Q3 		$708K Sell
292,692
-2,166,707
-88% -$5.74M ﹤0.01% 122
2021
Q2 		$7.8M Sell
2,459,399
-4,260,549
-63% -$14.3M 0.03% 84
2021
Q1 		$22.6M Buy
6,719,948
+689,655
+11% +$2.44M 0.1% 59
2020
Q4 		$21.6M Buy
+6,030,293
New +$15.1M 0.08% 55

Other funds holding MREO

RCMNY
Rubric Capital Management (New York) New York $9.44B AUM 68.42% 1-Year Est. Return
SCM
Soleus Capital Management Greenwich, Connecticut $2.47B AUM 115.63% 1-Year Est. Return
RSCM
Rock Springs Capital Management Baltimore, Maryland $1.7B AUM 93.03% 1-Year Est. Return
SCM
Suvretta Capital Management New York $3.92B AUM 86.67% 1-Year Est. Return
6CM
683 Capital Management New York $1.92B AUM 85.52% 1-Year Est. Return
MP
Mangrove Partners Greenwich, Connecticut $1.24B AUM 41.74% 1-Year Est. Return
Alkeon Capital Management
Alkeon Capital Management New York $59.5B AUM 51.63% 1-Year Est. Return
TC
Tejara Capital London, United Kingdom $303M AUM 5.43% 1-Year Est. Return
CC
Clearline Capital New York $1.93B AUM 38.13% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Baker Bros. Advisors's MREO Position: Q3 2023 in Review

Baker Bros. Advisors sold out of Mereo BioPharma (MREO) in Q3 2023, closing a stake of 3,554,979 shares — an estimated $4.69M sold.

Baker Bros. Advisors first reported a position in MREO in Q4 2020 and held it in 5 quarters. The position peaked at $22.6M in Q1 2021. 56 funds tracked by Wall St. Rank hold MREO as of Q3 2023.

  • Baker Bros. Advisors reported no remaining Mereo BioPharma position as of Q3 2023 after selling out during the quarter.
  • Baker Bros. Advisors sold 3,554,979 Mereo BioPharma shares in Q3 2023, an estimated $4.69M.
  • Baker Bros. Advisors first reported a position in Mereo BioPharma in Q4 2020 and held it in 5 quarters.
  • Baker Bros. Advisors's Mereo BioPharma position peaked at $22.6M in Q1 2021.
  • 56 funds tracked by Wall St. Rank held Mereo BioPharma as of Q3 2023.

Based on Baker Bros. Advisors's 13F filing for Q3 2023, filed 14 Nov 2023.